740 Hospital Avoidance Utilizing an ID Supervised OPAT Program

por Skorodin, Nathan, Petrak, Russell, Hines, David W., Fliegelman, Robert
Publicado 2014

Value and Clinical Impact of an Infectious Disease-Supervised Outpatient Parenteral Antibiotic Therapy Program

por Petrak, Russell M., Skorodin, Nathan C., Fliegelman, Robert M., Hines, David W., Chundi, Vishnu V., Harting, Brian P.
Publicado 2016

Early Tocilizumab Dosing Is Associated With Improved Survival in Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2

por Petrak, Russell M., Van Hise, Nicholas W., Skorodin, Nathan C., Fliegelman, Robert M., Chundi, Vishnu, Didwania, Vishal, Han, Alice, Harting, Brian P., Hines, David W.
Publicado 2021

A Real-World Assessment of Clinical Outcomes and Safety of Eravacycline: A Novel Fluorocycline

por Van Hise, Nicholas, Petrak, Russell M., Skorodin, Nathan C., Fliegelman, Robert M., Anderson, Michael, Didwania, Vishal, Han, Alice, Shah, Kairav, Chundi, Vishnu, Hines, David, Roig, Ingrid, Kalra, Apoorv
Publicado 2020

Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS‐CoV‐2

por Petrak, Russell M., Skorodin, Nathan C., Van Hise, Nicholas W., Fliegelman, Robert M., Pinsky, Jonathan, Didwania, Vishal, Anderson, Michael, Diaz, Melina, Shah, Kairav, Chundi, Vishnu V., Hines, David W., Harting, Brian P., Sidwha, Kamo, Yu, Brian, Brune, Paul, Owaisi, Anjum, Beezhold, David, Kent, Joseph, Vais, Dana, Han, Alice, Gowda, Neethi, Sahgal, Nishi, Silverman, Jan, Stake, Jonathan, Nepomuceno, Jenie, Heddurshetti, Renuka
Publicado 2021